|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shen L, Shan YS, Hu HM, Price TJ, Sirohi
B, Yeh KH, Yang YH, Sano T, Yang HK, Zhang X, et al: Management of
gastric cancer in Asia: Resource-stratified guidelines. Lancet
Oncol. 14:e535–e547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Flynn RA and Chang HY: Long noncoding RNAs
in cell-fate programming and reprogramming. Cell Stem Cell.
14:752–761. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and
Chang HY: Functional demarcation of active and silent chromatin
domains in human HOX loci by noncoding RNAs. Cell. 129:1311–1323.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao W, Dong S, Duan B, Chen P, Shi L, Gao
H and Qi H: HOTAIR is a predictive and prognostic biomarker for
patients with advanced gastric adenocarcinoma receiving
fluorouracil and platinum combination chemotherapy. Am J Transl
Res. 7:1295–1302. 2015.PubMed/NCBI
|
|
9
|
Xue Y, Gu D, Ma G, Zhu L, Hua Q, Chu H,
Tong N, Chen J, Zhang Z and Wang M: Genetic variants in lncRNA
HOTAIR are associated with risk of colorectal cancer. Mutagenesis.
30:303–310. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun X, Du P, Yuan W, Du Z, Yu M, Yu X and
Hu T: Long non-coding RNA HOTAIR regulates cyclin J via inhibition
of microRNA-205 expression in bladder cancer. Cell Death Dis.
6:e19072015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim K, Jutooru I, Chadalapaka G, Johnson
G, Frank J, Burghardt R, Kim S and Safe S: HOTAIR is a negative
prognostic factor and exhibits pro-oncogenic activity in pancreatic
cancer. Oncogene. 32:1616–1625. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang KC, Yang YW, Liu B, Sanyal A,
Corces-Zimmerman R, Chen Y, Lajoie BR, Protacio A, Flynn RA, Gupta
RA, et al: A long noncoding RNA maintains active chromatin to
coordinate homeotic gene expression. Nature. 472:120–124. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang YJ and Bikle DD: LncRNA profiling
reveals new mechanism for VDR protection against skin cancer
formation. J Steroid Biochem Mol Biol. 144:87–90. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Quagliata L, Matter MS, Piscuoglio S,
Arabi L, Ruiz C, Procino A, Kovac M, Moretti F, Makowska Z,
Boldanova T, et al: Long noncoding RNA HOTTIP/HOXA13 expression is
associated with disease progression and predicts outcome in
hepatocellular carcinoma patients. Hepatology. 59:911–923. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cheng Y, Jutooru I, Chadalapaka G, Corton
JC and Safe S: The long non-coding RNA HOTTIP enhances pancreatic
cancer cell proliferation, survival and migration. Oncotarget.
6:10840–10852. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Z, Zhao X, Zhou Y, Liu Y, Zhou Q, Ye H,
Wang Y, Zeng J, Song Y, Gao W, et al: The long non-coding RNA
HOTTIP promotes progression and gemcitabine resistance by
regulating HOXA13 in pancreatic cancer. J Transl Med. 13:842015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tsang FH, Au SL, Wei L, Fan DN, Lee JM,
Wong CC, Ng IO and Wong CM: Long non-coding RNA HOTTIP is
frequently up-regulated in hepatocellular carcinoma and is targeted
by tumour suppressive miR-125b. Liver Int. 35:1597–1606. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Deng HP, Chen L, Fan T, Zhang B, Xu Y and
Geng Q: Long non-coding RNA HOTTIP promotes tumor growth and
inhibits cell apoptosis in lung cancer. Cell Mol Biol
(Noisy-le-grand). 61:34–40. 2015.PubMed/NCBI
|
|
20
|
Zhang H, Zhao L, Wang YX, Xi M, Liu SL and
Luo LL: Long non-coding RNA HOTTIP is correlated with progression
and prognosis in tongue squamous cell carcinoma. Tumour Biol.
36:8805–8809. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: American Joint Committee on Cancer (AJCC)
Cancer Staging Handbook. 7th. Springer-Verlag; New York: 2010
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hartgrink HH, Jansen EP, van Grieken NC
and van de Velde CJ: Gastric cancer. Lancet. 374:477–490. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Khaitan D, Dinger ME, Mazar J, Crawford J,
Smith MA, Mattick JS and Perera RJ: The melanoma-upregulated long
noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer
Res. 71:3852–3862. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xie HW, Wu QQ, Zhu B, Chen FJ, Ji L, Li
SQ, Wang CM, Tong YS, Tuo L, Wu M, et al: Long noncoding RNA
SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and
associated with poor prognosis. Tumour Biol. 35:7743–7754. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang HM, Yang FQ, Yan Y, Che JP and Zheng
JH: High expression of long non-coding RNA SPRY4-IT1 predicts poor
prognosis of clear cell renal cell carcinoma. Int J Clin Exp
Pathol. 7:5801–5809. 2014.PubMed/NCBI
|
|
27
|
Liu H, Lv Z and Guo E: Knockdown of long
noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation,
metastasis and epithelial-mesenchymal transition. Int J Clin Exp
Pathol. 8:9140–9146. 2015.PubMed/NCBI
|
|
28
|
Shi Y, Li J, Liu Y, Ding J, Fan Y, Tian Y,
Wang L, Lian Y, Wang K and Shu Y: The long noncoding RNA SPRY4-IT1
increases the proliferation of human breast cancer cells by
upregulating ZNF703 expression. Mol Cancer. 14:512015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhao XL, Zhao ZH, Xu WC, Hou JQ and Du XY:
Increased expression of SPRY4-IT1 predicts poor prognosis and
promotes tumor growth and metastasis in bladder cancer. Int J Clin
Exp Pathol. 8:1954–1960. 2015.PubMed/NCBI
|
|
30
|
Sun M, Liu XH, Lu KH, Nie FQ, Xia R, Kong
R, Yang JS, Xu TP, Liu YW, Zou YF, et al: EZH2-mediated epigenetic
suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell
proliferation and metastasis by affecting the
epithelial-mesenchymal transition. Cell Death Dis. 5:e12982014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xie M, Nie FQ, Sun M, Xia R, Liu YW, Zhou
P, De W and Liu XH: Decreased long noncoding RNA SPRY4-IT1
contributing to gastric cancer cell metastasis partly via affecting
epithelial-mesenchymal transition. J Transl Med. 13:2502015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kelsey AD, Yang C, Leung D, Minks J,
Dixon-McDougall T, Baldry SE, Bogutz AB, Lefebvre L and Brown CJ:
Impact of flanking chromosomal sequences on localization and
silencing by the human non-coding RNA XIST. Genome Biol.
16:2082015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guil S and Esteller M: Cis-acting
noncoding RNAs: Friends and foes. Nat Struct Mol Biol.
19:1068–1075. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bai Y, Fang N, Gu T, Kang Y, Wu J, Yang D,
Zhang H, Suo Z and Ji S: HOXA11 gene is hypermethylation and
aberrant expression in gastric cancer. Cancer Cell Int. 14:792014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Han Y, Tu WW, Wen YG, Li DP, Qiu GQ, Tang
HM, Peng ZH and Zhou CZ: Identification and validation that
up-expression of HOXA13 is a novel independent prognostic marker of
a worse outcome in gastric cancer based on immunohistochemistry.
Med Oncol. 30:5642013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Degl' Innocenti D Rossi, Castiglione F,
Buccoliero AM, Bechi P, Taddei GL, Freschi G and Taddei A:
Quantitative expression of the homeobox and integrin genes in human
gastric carcinoma. Int J Mol Med. 20:621–629. 2007.PubMed/NCBI
|
|
37
|
Sentani K, Oue N, Naito Y, Sakamoto N,
Anami K, Oo HZ, Uraoka N, Aoyagi K, Sasaki H and Yasui W:
Upregulation of HOXA10 in gastric cancer with the intestinal mucin
phenotype: Reduction during tumor progression and favorable
prognosis. Carcinogenesis. 33:1081–1088. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Borrmann R: Geshwulste des magens und
duodenumsHenke F and Lubarsch O: Handbuch der speziellen
pathologischen anatomie und histologie. Springer-Verlag; Berlin:
pp. 8651926
|
|
39
|
Lauren P: The two histological main types
of gastric carcinoma: Diffuse and so-called intestinal-type
carcinoma. An attempt at a histo-clinical classification. Acta
Pathol Microbiol Scand. 64:31–49. 1965.PubMed/NCBI
|
